[
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc. (GILD) Jefferies Global Healthcare Conference (Transcript)",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) Jefferies Global Healthcare Conference June 4, 2025 11:05 PM ETCompany ParticipantsCindy Perettie - Executive Vice...",
    "url": "https://finnhub.io/api/news?id=4951d55034a5904599172daf4fa20af0d5e27ae437fd44941b3ebaf8bbce4b69",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749050363,
      "headline": "Gilead Sciences, Inc. (GILD) Jefferies Global Healthcare Conference (Transcript)",
      "id": 135014446,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) Jefferies Global Healthcare Conference June 4, 2025 11:05 PM ETCompany ParticipantsCindy Perettie - Executive Vice...",
      "url": "https://finnhub.io/api/news?id=4951d55034a5904599172daf4fa20af0d5e27ae437fd44941b3ebaf8bbce4b69"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Lunch: Wedbush Launches AI-Focused ETF",
    "summary": "Wedbush star tech analyst Dan Ives, known for his bullish AI thesis, see his namesake exchange-traded-fund launch today.",
    "url": "https://finnhub.io/api/news?id=9ef0e109be84d4dc2ec1c115a5f2eab68f4a09e607f105f2f834b29bcdc8f568",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749040140,
      "headline": "Wall Street Lunch: Wedbush Launches AI-Focused ETF",
      "id": 135011919,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1862938026/image_1862938026.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Wedbush star tech analyst Dan Ives, known for his bullish AI thesis, see his namesake exchange-traded-fund launch today.",
      "url": "https://finnhub.io/api/news?id=9ef0e109be84d4dc2ec1c115a5f2eab68f4a09e607f105f2f834b29bcdc8f568"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Gilead Sciences, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 11",
    "summary": "Presenter SpeechMichael Yee Good morning, everyone. Welcome to our next panel discussion with Gilead Sciences. We have a couple of important members of the executive team from Gilead here up with",
    "url": "https://finnhub.io/api/news?id=c9758cd9c3b6ddbe1074cb2608d8eec54128b3ee7dff11b0ea2b573dc48d0921",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749039619,
      "headline": "Transcript : Gilead Sciences, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 11",
      "id": 135011140,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Presenter SpeechMichael Yee Good morning, everyone. Welcome to our next panel discussion with Gilead Sciences. We have a couple of important members of the executive team from Gilead here up with",
      "url": "https://finnhub.io/api/news?id=c9758cd9c3b6ddbe1074cb2608d8eec54128b3ee7dff11b0ea2b573dc48d0921"
    }
  },
  {
    "ts": null,
    "headline": "HQL: Positive Outlook Due To Increased Healthcare Spending",
    "summary": "I maintain my buy rating on HQL due to its attractive 14% yield, discounted valuation, and long-term healthcare growth outlook.",
    "url": "https://finnhub.io/api/news?id=9031a7d42b96b38ba58b6b3765f535e4c89326fde198576909e01b7d1ffe4747",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749030762,
      "headline": "HQL: Positive Outlook Due To Increased Healthcare Spending",
      "id": 135009522,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1432883724/image_1432883724.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "I maintain my buy rating on HQL due to its attractive 14% yield, discounted valuation, and long-term healthcare growth outlook.",
      "url": "https://finnhub.io/api/news?id=9031a7d42b96b38ba58b6b3765f535e4c89326fde198576909e01b7d1ffe4747"
    }
  }
]